*ST聯合(600358.SH)完成收購新線中視28%股權
格隆匯 12 月 29日丨*ST聯合(600358.SH)公佈,2020年12月10日,公司董事會2020年第十次臨時會議審議通過了《關於公司收購新線中視28%股權暨關聯交易的議案》,同意公司以9940萬元現金收購關聯方樟樹市毅煒投資管理中心(有限合夥)(“毅煒投資”)持有的北京新線中視文化傳播有限公司(“新線中視”)28%股權。
2020年12月29日,公司收到北京市昌平區市場監督管理局於2020年12月28日出具的《備案通知書》,此次收購新線中視28%股權的工商備案登記已經完成,公司持有新線中視的股權比例變更為85.9305%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.